Portal Login:
  • Clients
  • Providers
  • Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar
  • Skip to footer
    Portal Login:
  • Clients
  • Providers
  • About MCN
  • Careers
  • MCNTalk
  • Contact Us

MCN | Medical Consultants Network

The Power of a Second Look

  • Services
    • Independent Medical Examinations
    • Medical Peer Reviews
    • Bill Review Services
    • Utilization Reviews
  • Expertise
    • Short and Long-Term Disability
    • Workers’ Compensation
    • Auto/PIP/Casualty/Liability
    • Independent Review Organization Services
  • For Clients
  • For Providers
  • Your Exam
    • About Your Exam
    • About Your External Review
    • Contact & Scheduling
  • Schedule Now
  • About MCN
  • MCNTalk
  • Careers
  • Contact Us

MCNTalk
News, Insights & Opinions

Home / MCNTalk / Fentanyl Penetrating Illegal Drug Markets in the United Stat...

July 12, 2016

Fentanyl Penetrating Illegal Drug Markets in the United States

Last week we shared two articles that expressed the dangers surrounding the drug Fentanyl, and the disturbing actions a pharmaceutical company has taken to ensure a high rate of sales. Over the past few months Fentanyl has made news for numerous reasons — most prominently as the drug involved in the musician Prince’s death from overdose. An article published in the New York Times last week now discusses the interest that Mexican cartels are taking in the drug because of its extreme potency and profitability in the United States. States like California, Massachusetts, and New Hampshire have had alarming rises in overdose deaths and have seen Fentanyl penetrating their drug markets, for which officials are blaming Mexico’s cartels and warn that they are using their own labs to produce the drug. There are some experts who are wary about overemphasizing the role of cartels due to a lack of hard data showing how extensive their involvement may be. However, a possible reason that Fentanyl is not showing up in the majority of drug seizures in Mexico is because the Mexican authorities have not been testing for it. Meanwhile, American law enforcement across the United States has seen a massive rise in recovered Fentanyl, from 640 samples tested in 2010 to 13,002 samples tested last year.

Share this:

  • Twitter
  • Email
  • More
  • Facebook
  • Reddit
  • Print

Leave a Comment

Previous Post
Next Post

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Recent Posts

  • The Quality Divide: What Makes a Quality IME Physician?
  • The Quality Divide: Is Your Vendor Driving IME Excellence?
  • The Quality Divide: When and How to Request an IME?
  • April Clinic Calendars Are Available
  • MCN’s Client Portal Login Page is Changing

Archives

Footer


  • Twitter
  • LinkedIn

Quick Links

  • Services
  • Expertise
  • About MCN
  • Careers

Division Headquarters

MCN
1200 5th Ave., Ste. 650
Seattle, WA 98101

See all offices

Email Us

General Inquiries: info@mcn.com
Sales & Marketing: marketing@mcn.com

Call Us

206.343.6100
800.248.6269

© Copyright 2023 Mitchell International, Inc. All Rights Reserved.

  • Privacy Policy
  • Sitemap